Recently, the roles of 2′,3′-cyclic nucleotide-3′-phosphodiesterase (CNPase) in the pathophysiological processes of heart diseases have emerged, as indicated by our group targeting CNPase enzymatic activity, which might represent a novel therapeutic strategy for heart failure [8]. Here, CNP is linked to heart failure.